[MYGN] YoY Quarter Result on 31-Dec-2014 [#Q4]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
04-Feb-2015
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- 50.36%
YoY- -52.28%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 194,000 196,500 193,300 184,393 204,060 149,140 122,811 7.91%
PBT 3,700 12,100 45,000 37,940 84,144 56,985 46,783 -34.45%
Tax -28,400 6,200 14,700 13,909 33,784 21,949 18,487 -
NP 32,100 5,900 30,300 24,031 50,360 35,036 28,296 2.12%
Tax Rate 767.57% -51.24% -32.67% -36.66% -40.15% -38.52% -39.52% -
Total Cost 161,900 190,600 163,000 160,362 153,700 114,104 94,515 9.37%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin 16.55 3.00 15.68 13.03 24.68 23.49 23.04 -5.36%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS 0.46 0.09 0.43 0.33 0.67 0.43 0.33 5.68%
EPS Diluted 0.45 0.09 0.41 0.32 0.66 0.42 0.33 5.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.